Abstract
Criticism of HL ruling that patent for hepatitis B virus antigen was invalid because claim was too broad, insufficiently inventive and unsupported by disclosure.
| Original language | English |
|---|---|
| Pages (from-to) | 301-310 |
| Number of pages | 10 |
| Journal | International Journal of Biosciences and the Law |
| Volume | 1 |
| Issue number | 3 |
| Publication status | Published - 1 Jan 1997 |
| Externally published | Yes |
